Arzerra
Overview ( Several members taking Arzerra )
This product is used for the treatment of patients with chronic lymphocytic leukemia, a cancer of the blood. It is a CD20-directed cytolytic monoclonal antibody.
This product has boxed warning related to the risk reactivation of hepatitis B virus infection.
What is your Risk Rating for this medicine?
The risk of serious side effects for taking this medicine can be different if you take other medicines or if you suffer from a condition. Get your Risk Rating by creating a profile in a few steps.
Benefits:
- We monitor your health and alert you to any safety updates and recalls.
- You get to talk directly to other members about their experience.
- You can create profiles for you and your loved ones.
Drug Interaction
We check for possible drug-drug or drug-condition interactions for your medical treatment so you know when there is an issue. Drug interactions may create serious side effects that you want to discuss with your doctor.
Register to check interactions


